Country: United States
Language: English
Source: NLM (National Library of Medicine)
AMANTADINE HYDROCHLORIDE (UNII: M6Q1EO9TD0) (AMANTADINE - UNII:BF4C9Z1J53)
American Health Packaging
AMANTADINE HYDROCHLORIDE
AMANTADINE HYDROCHLORIDE 100 mg
ORAL
PRESCRIPTION DRUG
Amantadine hydrochloride capsules, USP are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride capsules, USP are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. Amantadine hydrochloride capsules, USP are indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection. Because amantadine does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. Following vaccination during an influenza A outbreak, amantadine prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response. Amantadine hydrochloride capsules, USP are also indicated in the treatment of uncomplicated respiratory tract illness caused by influenza A vi
Amantadine hydrochloride capsules, USP for oral administration are available as: 100 mg: Red capsules imprinted GG 634 and supplied as: Unit dose packages of 100 (10 x 10) NDC 68084-611-01 Store at 20° to 25°C (68° to 77°F) (see USP Controlled Room Temperature). FOR YOUR PROTECTION: Do not use if blister is torn or broken.
Abbreviated New Drug Application
AMANTADINE HYDROCHLORIDE- AMANTADINE HYDROCHLORIDE CAPSULE AMERICAN HEALTH PACKAGING ---------- AMANTADINE HYDROCHLORIDE CAPSULES, USP 8261101/0117 RX ONLY DESCRIPTION: Amantadine hydrochloride, USP is designated chemically as 1-adamantanamine hydrochloride. Its molecular weight is 187.71 with a molecular formula C H NCl. It has the following structural formula: Amantadine hydrochloride, USP is a stable white or nearly white crystalline powder, freely soluble in water and soluble in alcohol and in chloroform. Amantadine hydrochloride, USP has pharmacological actions as both an anti-Parkinson and an antiviral drug. Amantadine hydrochloride, USP is available as 100 mg capsules for oral administration. Inactive ingredients: corn starch, croscarmellose sodium, ethylcellulose, magnesium stearate, microcrystalline cellulose, and pregelatinized starch. The capsule shells and imprinting ink contain: ammonium hydroxide, FD&C Blue #1, FD&C Red #40, gelatin, methylparaben, , propylene glycol, propylparaben, shellac, simethicone, sodium lauryl sulfate, and titanium dioxide. CLINICAL PHARMACOLOGY: PHARMACODYNAMICS : _MECHANISM OF ACTION:_ _ANTIVIRAL:_ The mechanism by which amantadine exerts its antiviral activity is not clearly understood. It appears to mainly prevent the release of infectious viral nucleic acid into the host cell by interfering with the function of the transmembrane domain of the viral M2 protein. In certain cases, amantadine is also known to prevent virus assembly during virus replication. It does not appear to interfere with the immunogenicity of inactivated influenza A virus vaccine. _ANTIVIRAL ACTIVITY:_ Amantadine inhibits the replication of influenza A virus isolates from each of the subtypes, i.e., H1N1, H2N2 and H3N2. It has very little or no activity against influenza B virus isolates. A quantitative relationship between the _in vitro_ susceptibility of influenza A virus to amantadine and the clinical response to therapy has not been established in man. Sensitivity test results, expressed as the co Read the complete document